Figure 1
![Figure 1. The progressive changes of hematologic parameters (hemoglobin [Hb], white blood cell count [WBC], and platelet count [PLT]; on the left y-axis) and of JAK2V617F allele burden (percent value; on the right y-axis) in samples collected at different times after AML diagnosis. Clinically relevant events (diagnosis of AML or PV, autologous hematopoietic stem-cell transplantation [HSCT], and onset of pruritus) are marked by arrows on the top of the figure.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/110/13/10.1182_blood-2007-07-103267/3/zh80010810700001.jpeg?Expires=1724243391&Signature=h5plkm59l5~2SGu-lObbhOMkoRP0R41~YokrUiiwmtKakdGWJatlED3q9G8mePwgER7oP4TdM4MNVlGXZPTxAJVj9-3PRCHS9ZzRWQcfVEOUCYG0y~TjbWkHaeZDT4HSJ8AX~4sX45FnrrPm3bZBA9bDi0CaiHdZEXVlk6RZ46XnwOdLMKMr~E3Zh3F9znXIGhmKlFa13r2xy2ABXWH7DC7Sht2~yHyDByCLQH1LZ~GAGLRuGu3dAUixqwVEnhiS4ZObgLygu7fH5Pmtvy0XZgs58CyVe0m91QgT6Wlu6-NXwxQsssMQNjvVseFmA2S21TnY58AQgD~leihL39V2ZQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
The progressive changes of hematologic parameters (hemoglobin [Hb], white blood cell count [WBC], and platelet count [PLT]; on the left y-axis) and of JAK2V617F allele burden (percent value; on the right y-axis) in samples collected at different times after AML diagnosis. Clinically relevant events (diagnosis of AML or PV, autologous hematopoietic stem-cell transplantation [HSCT], and onset of pruritus) are marked by arrows on the top of the figure.
